Target intelligence / Profile preview

Sodium channel protein type 1, 2, and 3 subunit alpha (Nav1.1 (SCN1A), Nav1.2 (SCN2A), Nav1.3 (SCN3A))

Target
Nav1.1 (SCN1A), Nav1.2 (SCN2A), Nav1.3 (SCN3A)
Molecular classification
Ion channel
01

Overview

Sodium channel protein type 1, 2, and 3 subunit alpha are the core pore-forming subunits of voltage-gated sodium channels (Nav1.1, Nav1.2, Nav1.3), essential for the initiation and propagation of action potentials in neurons and muscle cells[1][2][6]. These channels are transmembrane proteins comprising four homologous domains, each containing six transmembrane segments; their S4 segments act as voltage sensors, conferring voltage-dependent gating[1][2]. The channels are critical for rapid depolarization of excitable cells, and mutations in the encoding genes (SCN1A, SCN2A, SCN3A) are linked to various neurological disorders, including epilepsy and developmental encephalopathies[4][6]. Voltage-gated sodium channels are major drug targets for anticonvulsants, local anesthetics, and antiarrhythmics, which act predominantly by blocking or stabilizing inactive conformations of these channels[2][4].

Other names
Voltage-gated sodium channel alpha subunitNav1.1Nav1.2Nav1.3SCN1ASCN2ASCN3A
02

Mechanism of action

Blockade of sodium ion flux through channel pore; Stabilization of inactivated channel state; Inhibition of repetitive neuronal firing

03

Biological functions

Action potential initiationAction potential propagationElectrophysiological signaling in neurons and muscle
04

Disease associations

EpilepsyNeuropathic painNeurodevelopmental disordersCardiac arrhythmia (for select types)
05

Safety considerations

Risk of CNS toxicity (e.g., seizures)Cardiac arrhythmias (with non-selective blockers)Potential respiratory depression
06

Interacting drugs

Lidocaine

7 more in the full profile.

07

Biomarkers

SCN1A, SCN2A, SCN3A gene mutations (for epilepsy subtypes and pharmacogenetics)

Beyond the preview

Go deeper on Sodium channel protein type 1, 2, and 3 subunit alpha (Nav1.1 (SCN1A), Nav1.2 (SCN2A), Nav1.3 (SCN3A)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium channel protein type 1, 2, and 3 subunit alpha (Nav1.1 (SCN1A), Nav1.2 (SCN2A), Nav1.3 (SCN3A)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call